Abstract
Genome-wide association studies identified >50 type 1 diabetes (T1D) associated non-human leukocyte antigens (non-HLA) loci. The purpose of this study was to assess the contribution of non-HLA single nucleotide polymorphisms (SNPs) to risk of disease progression. The TrialNet Pathway to Prevention Study follows relatives of T1D patients for development of autoantibodies (Abs) and T1D. Using the Immunochip, we analyzed 53 diabetes-associated, non-HLA SNPs in 1016 Ab-positive, at-risk non-Hispanic white relatives. Effect of SNPs on the development of multiple Abs and T1D. Cox proportional analyses included all substantial non-HLA SNPs, HLA genotypes, relationship to proband, sex, age at initial screening, initial Ab type, and number. Factors involved in progression from single to multiple Abs included age at screening, relationship to proband, HLA genotypes, and rs3087243 (cytotoxic T lymphocyte antigen-4). Significant factors for diabetes progression included age at screening, Ab number, HLA genotypes, rs6476839 [GLIS family zinc finger 3 (GLIS3)], and rs3184504 [SH2B adaptor protein 3 (SH2B3)]. When glucose area under the curve (AUC) was included, factors involved in disease progression included glucose AUC, age at screening, A...Continue Reading
References
Mar 29, 2003·Diabetes·Valma HyttinenJaakko Tuomilehto
May 23, 2006·Nature Genetics·Valérie SenéeCécile Julier
Oct 1, 2008·Pediatric Diabetes·Jeffrey L MahonUNKNOWN Type 1 Diabetes TrialNet Study Group
Nov 4, 2008·Nature Genetics·Jason D CooperJohn A Todd
Dec 17, 2008·The New England Journal of Medicine·Deborah J SmythJohn A Todd
Dec 26, 2008·The New England Journal of Medicine·Maria J RedondoTihamer Orban
May 12, 2009·Nature Genetics·Jeffrey C BarrettUNKNOWN Type 1 Diabetes Genetics Consortium
Oct 7, 2009·Molecular and Cellular Biology·Hong Soon KangAnton M Jetten
May 1, 2010·Nature·Jeffrey A BluestoneGeorge Eisenbarth
Jul 3, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Josyf C MychaleckyjUNKNOWN T1DGC
Oct 13, 2010·Nucleic Acids Research·Oliver S BurrenJohn A Todd
Jul 2, 2011·Lancet·Tihamer OrbanUNKNOWN Type 1 Diabetes TrialNet Abatacept Study Group
Feb 9, 2012·Diabetes·Andrea K SteckMarian J Rewers
Aug 7, 2013·Nature Reviews. Genetics·Miles ParkesMatthew A Brown
Nov 20, 2013·Acta Diabetologica·Ezio BonifacioAnette-Gabriele Ziegler
Dec 4, 2013·Diabetes Care·Tihamer OrbanUNKNOWN Type 1 Diabetes TrialNet Abatacept Study Group
Apr 2, 2014·Immunologic Research·Zhongyan ShanSara A Michie
Jul 31, 2014·Pediatric Diabetes·Andrea K SteckMarian J Rewers
Sep 5, 2014·Diabetologia·Christiane WinklerEzio Bonifacio
Nov 26, 2014·Diabetes·Carina TörnUNKNOWN TEDDY Study Group
Dec 30, 2014·Diabetes Care·UNKNOWN American Diabetes Association
Mar 10, 2015·Nature Genetics·Suna Onengut-GumuscuStephen S Rich
Sep 24, 2015·Current Diabetes Reports·Tina FløyelFlemming Pociot
Dec 17, 2016·Diabetes·Jay S SkylerRobert E Ratner
Citations
May 18, 2018·Diabetes·Carla J GreenbaumMark A Atkinson
Jul 28, 2018·Pediatric Diabetes·Jennifer J CouperMaria E Craig
Apr 11, 2019·Journal of Diabetes Investigation·Hiroshi OnumaHideichi Makino
Jun 21, 2019·Current Opinion in Endocrinology, Diabetes, and Obesity·Richard A Oram, Maria J Redondo
Jun 7, 2019·Diabetes Care·Maria J RedondoJay Sosenko
Nov 23, 2019·Diabetologia·Laura A ClaessensBart O Roep
Jun 23, 2018·Diabetologia·Mustafa TosurUNKNOWN Type 1 Diabetes TrialNet Study Group
Nov 21, 2017·Biomedicine Hub·Richard InselJoseph Hedrick
Nov 7, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eric J AllenspachDavid J Rawlings
Jul 8, 2021·Scientific Reports·Denis M NyagaJustin M O'Sullivan